Skip to content

Clinical trials

Phase 2 Neoplasms by Site trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms by Site Phase: Phase 2 Country / region: China Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20181
20191
20203
20211
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status4
Active, not recruiting2
Recruiting2
Completed1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Xiaoxiang Chen2
Jiangxi Provincial Cancer Hospital1
Nanfang Hospital, Southern Medical University1
Shandong Cancer Hospital and Institute1
Sinocelltech Ltd.1
The Second Affiliated Hospital of Fujian Medical University1
Wenjun Cheng1
Zhejiang University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms by Site9
Neoplasms6
Neoplasms by Histologic Type5
Carcinoma4
Digestive System Neoplasms4
Neoplasms, Glandular and Epithelial4
Carcinoma, Ovarian Epithelial3
Digestive System Diseases3
Genital Diseases, Female3
Genital Neoplasms, Female3

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.